Strategies for Prevention and Treatment of Trichomonas vaginalis Infections

Clin Microbiol Rev. 2017 Jul;30(3):811-825. doi: 10.1128/CMR.00109-16.

Abstract

The last estimated annual incidence of Trichomonas vaginalis worldwide exceeds that of chlamydia and gonorrhea combined. This critical review updates the state of the art on advances in T. vaginalis diagnostics and strategies for treatment and prevention of trichomoniasis. In particular, new data on treatment outcomes for topical administration of formulations are reviewed and discussed.

Keywords: Trichomonas vaginalis.

Publication types

  • Review

MeSH terms

  • Administration, Topical
  • Antiprotozoal Agents / administration & dosage
  • Antiprotozoal Agents / therapeutic use*
  • Humans
  • Trichomonas Infections / diagnosis
  • Trichomonas Infections / drug therapy*
  • Trichomonas Infections / prevention & control*
  • Trichomonas vaginalis / physiology

Substances

  • Antiprotozoal Agents